G-103 (Gibson Oncology)

N/A

Report date: 2025/12/12 15:31:04
NME

Base Information

Drug NameG-103 (Gibson Oncology)
Drug Alias NameG-103
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGibson Oncology LLC
China Registration ClassN/A

Develop Information

Active CompaniesGibson Oncology LLC
Inactive CompaniesN/A
Active IndicationsSolid tumoursAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A